dr. robson on the potential utility of tucatinib in her2 breast cancer
Published 4 years ago • 136 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
3:08
the benefits of tucatinib in her2 breast cancer
-
1:36
dr. robson on the application of precision medicine in breast cancer
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:13
dr. krill-jackson on the potential utility of trastuzumab deruxtecan in metastatic breast cancer
-
1:18
dr. robson on exploratory analysis from olympiad in breast cancer
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:45
dr. chien on tucatinib in her2 breast cancer
-
3:15
a close look at tucatinib in her breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
3:35
understanding the her2climb trial
-
1:11
dr. accordino on the utility of cdk4/6 inhibitors in hr /her2– breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
1:21
dr. park on the benefit of trastuzumab deruxtecan in her2 breast cancer